Skip to Main Content

Paper Details

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Brain
25
2020
Author NameAffiliation
Lisanne J BalkVU University Medical Center
Benjamin KnierTechnische Universitat Munchen
Thomas KornTechnische Universitat Munchen
Thomas Korn
Joachim HavlaInstitute of Clinical Neuroimmunology, Ludwig-Maximilians University
Joachim HavlaLudwig-Maximilians University
Elena H Martinez-LapiscinaHospital Clinic, University of Barcelona, Institut d'Investigacio Biomedica August Pi i Sunyer (IDIBAPS)
Hanna ZimmermannNeuroCure Clinical Research Center and Experimental and Clinical Research Center, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health and Max Delbrueck Center for Molecular Medicine
Friedemann PaulNeuroCure Clinical Research Center and Experimental and Clinical Research Center, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health and Max Delbrueck Center for Molecular Medicine
Alexander U BrandtNeuroCure Clinical Research Center and Experimental and Clinical Research Center, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health and Max Delbrueck Center for Molecular Medicine
Alexander U BrandtUniversity of California irvine
Shiv SaidhaJohns Hopkins Hospital
Peter A CalabresiJohns Hopkins Hospital
Hans-Peter HartungHeinrich-Heine University Dusseldorf
  • 1 - 14

Datasets